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Abstract
Background: Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive
neoplasm. The cytological diagnosis of these tumors can be difficult because they show
morphological features quite similar to other small round blue cells tumors. We described four
cases of DSRCT with cytological sampling: one obtained by fine needle aspiration biopsy (FNAB)
and three from serous effusions. The corresponding immunocytochemical panel was also reviewed.
Methods:  Papanicolaou stained samples from FNAB and effusions were morphologically
described. Immunoreaction with WT1 antibody was performed in all cytological samples. An
immunohistochemical panel including the following antibodies was performed in the corresponding
biopsies: 34BE12, AE1/AE3, Chromogranin A, CK20, CK7, CK8, Desmin, EMA, NSE, Vimentin and
WT1.
Results: The smears showed high cellularity with minor size alteration. Nuclei were round to oval,
some of them with inconspicuous nucleoli. Tumor cells are clustered, showing rosette-like feature.
Tumor cells in effusions and FNA were positive to WT1 in 3 of 4 cytology specimens (2 out 3
effusions and one FNA). Immunohistochemical reactions for vimentin, NSE, AE1/AE3 and WT1
were positive in all cases in tissue sections.
Conclusion:  The use of an adjunct immunocytochemical panel coupled with the
cytomorphological characteristics allows the diagnosis of DSRCT in cytological specimens.
Introduction
Desmoplastic small round cell tumor (DSRCT) is a rare
and highly aggressive neoplasm described as a distinct
clinicopathologic entity in 1989 by Gerald and Rosai [1].
Usually affecting young males and presenting as an
abdominal mass, the tumor grows along serosal mem-
branes with multiple nodules attached to the peritoneal
surface [2]. Other primary sites have been reported as
pleura [3], paratesticular region [4], bone and soft tissues
[5] and ovary [6,7].
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Histologically, a typical feature of DSRCT is the presence
of clusters of tumor cells distributed within a cellular
stroma. The shape of clusters varies from round to elon-
gate. Tumor cells are small to medium-sized with round
to oval hyperchromatic nuclei, with inconspicuous nucle-
oli. Necrotic cells and mitosis are common features. Cyto-
plasm is usually scanty, and cell borders are indistinct.
Intracytoplasmic eosinophilic rhabdoid inclusions may
be found in larger cells with nuclear pleomorphism [8].
The immunohistochemical profile shows divergent differ-
entiation, a striking feature of this tumor. DSRCT may
present a problem in the differential diagnosis with other
round cell tumors. Tumor cells are immunoreactive for
epithelial, neural and myogenic markers [2]. Cytogeneti-
cal studies have demonstrated a reciprocal chromosome
translocation between the Ewing's sarcoma gene on chro-
mosome 22 and the Wilms' tumour gene WT1 on chro-
mosome 11, which is distinct from the translocation
observed in Ewing sarcoma/peripheral neuroectodermal
tumor (PNET) [9].
The cytological smears of DSRCT obtained by FNAB are
moderately cellular. Tumor cells show round to oval
nuclei with fine chromatin and inconspicuous nucleoli.
Cytoplasm is scanty to moderate, with variable number of
vacuoles. Tumor cells are arranged in loose clusters. Occa-
sionally, spindle fibroblast-like cells are observed. Stro-
mal fragments may be detected [10]. Effusion samples
show cohesive cell clusters and similar cytological fea-
tures. Mitoses or individual necrotic cells may be present,
as nuclear molding [3]. In the current study, we describe
the morphological and immunocytochemical features of
four cytologic specimens, one of them obtained by FNAB
and three from serous effusions (2 peritoneal fluid sam-
ples and one pleural effusion), from 3 patients with a
diagnosis of DSRCT.
Materials and methods
We retrieved from the cytological files of Hospital do Can-
cer – A. C. Camargo four cytological specimens from 3
patients diagnosed with DSRCT, including one fine-nee-
dle aspiration sample and 3 fluid samples, during the last
five years (2000–2004). FNA was performed on an
inguinal mass of one patient. Alcohol-fixed smears were
stained with Papanicolaou technique. Serous effusions
were prepared with Cytospin (Shandon, Pittsburgh, Penn-
sylvania, USA). We evaluated two peritoneal fluid sam-
ples and one pleural fluid sample. One case (patient 1,
peritoneal fluid) had a cellblock available. All cases were
confirmed by histological analysis and immunohisto-
chemical reactions. The histological sections were cut in
sections of 4 µm and stained with H&E and immunohis-
tochemistry. Immunocytochemical study was also per-
formed on all cases.
Immunohistochemical and immunocytochemical reac-
tions were performed using streptavidin-biotin peroxi-
dase technique with positive and negative controls.
Diaminobenzidine was the chromogen. Table 1 shows the
antibodies used and dilutions. All antibodies were from
DAKO Corporation, Capinteria, CA, U.S.A.
Cases
Patient 1
22-year-old white female, with abdominal pain. Video-
laparoscopy showed a liver mass and multiple peritoneal
implants diagnosed as DSRCT. Six months after the diag-
nosis, she started chemotherapy for four months, and
reduction of tumor mass was observed. One month after
the end of chemotherapy, the tumor was removed. Macro-
scopically, tumor mass measured 5.0 × 4.0 × 3.8 cm and
was involving uterus, pericolic tissue, and vagina. Histo-
logical analysis shows also involvement of both ovaries
and large bowel wall. Ten out of 13 lymph nodes showed
metastasis of DSRCT. The peritoneal fluid colleted during
surgery was negative for neoplastic cells. Eight months
after the first surgery, she presented with a recurrence in
the abdominal cavity and a new resection of the tumor
mass showed involvement of cecal appendix. Peritoneal
fluid sample collected at that time was positive for malig-
nant cells. In the follow up examination, seven months
after the second surgery, it was found an inguinal tumor
mass of 15 mm. FNA was performed and showed DSRCT
metastasis. After the diagnosis, this patient was transferred
to another institution.
Patient 2
Seven year-old male with back pain and fever. CT scan
showed pleural effusion and a mediastinal mass measur-
ing 16.0 × 9.0 cm. Tumour mass showed involvement of
soft tissues. Surgical biopsy and pleural drainage were
Table 1: Antibodies and dilutions used in this study
Marker Antibody clone Dilution
34BE12 34BE12 1:100
AE1/AE3 AE1/AE3 1:500
Chromogranin A DAK-A3 1:100
CK20 KS20.8 1:50
CK7 OV-TL 12/30 1:100
CK8 35BH11 1:100
Desmin D33 1:100
EMA E29 1:2000
NSE BBS/NC/V1-H14 1:1500
Vimentin Vim 3B4 1:200
WT1 6F-H2 1:400CytoJournal 2005, 2:6 http://www.cytojournal.com/content/2/1/6
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performed. The patient was treated with radiotherapy and
chemotherapy, but died 8 months after the diagnosis.
Patient 3
Male, 15-year-old had acute abdominal pain and was sub-
mitted to an exploratory laparotomy that disclosed a large
pelvic mass, involving epiplon and sigmoid, cecum, liver
and peri-aortic lymph nodes. This patient had multiple
nodules on peritoneal surface. The biopsy of tumor was
performed. One month after the diagnosis, chemotherapy
was initiated. The patient was submitted to chemotherapy
during 8 months, with reduction of more than 50% of
tumor mass. A second laparotomy was done to excise ret-
roperitoneal and retrovesical mass. At this time peritoneal
fluid sample was collected. After surgery, chemotherapy
was continued. The patient is alive, with residual disease.
Results
Cytological findings
Case 1 (Fine needle aspiration)
The smears showed high cellularity. The tumor cells
exhibited a slight variation in size. Nuclei were round to
oval, some of them with small nucleoli. The cytoplasm
was scanty. Tumor cells are clustered, with rare clusters
showing rosette-like features. The background of the
smears showed lymphocytes. (Figure 1).
Cases 1, 2 and 3
All fluid samples showed similar features. The samples
showed high cellularity. Tumor cells were more frequently
arranged in tridimentional clusters, but occasionally, iso-
lated cells are also seen. Additionally, clusters showing
rosette-like features are rarely observed. Nuclei were
round to oval, some of them with small nucleoli. The
cytoplasm was scanty (Figure 2).
Clusters of small round tumor cells showing rosette-like fea- tures in smear of fine needle aspiration specimen of DSRCT Figure 1
Clusters of small round tumor cells showing rosette-like fea-
tures in smear of fine needle aspiration specimen of DSRCT.
Effusion from patient with DSRCT exhibiting high cellularity Figure 2
Effusion from patient with DSRCT exhibiting high cellularity. 
Observe tridimentional clusters of neoplastic cells. Nuclei 
were round to oval, some of them with small nucleoli and 
the cytoplasm is scanty.
DSRCT tumor cells in effusion showing nuclear positive reac- tion to WT1 Figure 3
DSRCT tumor cells in effusion showing nuclear positive reac-
tion to WT1.CytoJournal 2005, 2:6 http://www.cytojournal.com/content/2/1/6
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Immunohistochemical and Immunocytochemical findings
The distribution of immunoreactivity in histological and
cytological samples from the patients are summarized in
Table 2. Tumor cells in effusions from patients 1 and 2
and, the smear obtained by FNA (Patient 1) were positive
to WT1 (Figure 3).
Patient 1
the histological sample collected before chemotherapy,
exhibited immunohistochemical positivity for vimentin,
epithelial membrane antigen (EMA), neuron specific
enolase (NSE), chomogranin A, and desmin in dot-like
perinuclear pattern. Cytokeratin expression was observed
with anti-cytokeratin cocktail (AE1/AE3) and Cytokeratin
8. Tumor cells also expressed WT1 protein.
Patient 2
tumor cells exhibited positivity for vimentin, EMA, NSE,
chomogranin A, AE1/AE3 and WT1. Desmin and cytok-
eratins 7, 20 and 34BE12 were negative.
Patient 3
tumor cells exhibited positivity for vimentin, NSE, AE1/
AE3 and WT1. The immunohistochemical study was per-
formed before chemotherapy.
Discussion
DSRCT is a rare neoplasm that affects young patients. It
may present a problem in the differential diagnosis with
other small round cell tumors. The diagnosis of DSRCT
however can be established with correlation of clinical,
cytological and immunocytochemical features. The
cytological features that we found in the smears obtained
by FNA are similar to other descriptions in the literature.
Similar to reports of Zeppa et al [11], we did not detect in
our smears fragments of fibrosis or cytoplasmic granules
or vacuoles. The finding of stromal fragments, frequently
seen in FNA is not a common finding in liquid based
preparations [12].
One of the characteristics of DSRCTs is its dissemination
along serous surfaces. Due to this fact, development of
serous effusions is a common clinical finding in DSRCTs
patients, with detection of tumor cells in the fluid. In effu-
sions, tumor cells may be present in aggregates but no
obviously architectural arrangement is seem.
Demonstration of a divergent phenotype and the recipro-
cal translocation characteristic of DSRCT are critical to the
diagnosis.
In a reported series of 32 cases of DSRCTs [13], 88% of
cases were immunoreactive for AE1/AE3, 84% for NSE,
81% for desmin. These results were similar to other previ-
ous studies [2]. Lae et al [13] detected positivity to WT1
antibody in 29 out of 32 cases. Our immunohistochemi-
cal results are in agreement with other previous studies.
Strong membrane expression of HER2/neu and immuno-
reactivity to c-kit protein are not common findings [14].
The establishment of a specific reciprocal translocation t
(11; 22)(p13;12) as diagnostic in DSRCT was based on
the results of Sawyer et al [9]. Shen et al [15] and Roberts
et al [16] described variants of with other chromosome
involved in addition to chromosome 11 and 22. The
translocation t (11; 22)(p13;12) involve the EWS gene in
22q24 and WT1 gene in 11p13. This translocation pro-
duces the chimeric transcript EWS/WT1 and the related
WT1 protein, which can be detected by immunohisto-
chemical method.
Table 2: Distribution of immunoreactions in patients 1, 2 and 3 histological and cytological samples.
Marker Patient 1 Biopsy Patient 2 Biopsy Patient 3 Biopsy Patient 1 
Cytology
Patient 2 
Cytology
Patient 3 
Cytology
34BE12 - - ND ND ND ND
AE1/AE3 + + + ND ND ND
Chromogranin A + + ND ND ND ND
CK20 - - ND ND ND ND
C K 7 - - N DN DN DN D
C K 8 + - N DN DN DN D
Desmin + - ND ND ND ND
E M A + + N DN DN DN D
NSE + + + ND ND ND
Vimentin + + + ND ND ND
W T 1 +++++-
(Effusion & FNA)
N.D. = not done.CytoJournal 2005, 2:6 http://www.cytojournal.com/content/2/1/6
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EWS gene encodes a protein which the precise function
and normal role has not yet been elucidated. Recently,
Thomas et al [17] proposed that the protein product of the
EWS gene interacts with Brn-3a cellular transcription fac-
tor via a direct protein-protein interaction. Native WT1
protein function has not completely known, but it
represses transcription in vitro of many genes. WT1 is a
tumor-suppressor gene that encodes a protein, which
mediates transcriptional repression and interacts with p53
protein [18], product of another tumor suppressor gene,
TP53, frequently deleted or mutated in many human
tumors. In absence of intact p53 protein, WT1 acts as a
transcriptional activator [19]. Normal WT1 protein is
expressed in tissues, which undergo mesenchymal-epithe-
lial conversion derived from mesoderm, in a specific
period of development [20] and it plays a role in mesothe-
lial formation in embryonic development [21].
Immunohistochemical detection of WT1 in DSRCTs is
predictive of the translocation and it also demonstrates
that the chimeric protein is expressed in significant
amount in tumour cells 22, 23. In addiction to consistent
WT1 expression, the typical serosal involvement in
DSRCT has raised the possibility that this tumor might be
a blastematous tumour derived of primitive mesothelium
[24]. Mesothelin is a glycoprotein of unknown function
strongly expressed in mesothelial cells. Although lack of
specificity of expression of mesothelin for mesothelial ori-
gin, the expression of this protein in DSRCT may have
some significance on histogenisis of this tumor [25].
We detected WT1 immunoreactivity in all tumors tissues
and in 2 out of 3 serous effusions with malignant cells, as
well as on FNAB smears. The high frequency of DSRCTs
with WT1 protein expression suggests that in consensus
with clinical tomographic and cytological findings, this
antibody may be used to confirm the diagnosis of DSRCT
in cytological samples. We observed a negative WT1 reac-
tion in the cytological sample of patient 3. This sample
was collected 10 months after the end of chemotherapy
protocol. We can hypothesize if chemotherapy hampered
a different antigenic pattern in malignant cells, and influ-
enced this result.
Among other small round cell tumors, most of cases of
rhabdomyosarcomas and neuroblastomas do not disclose
nuclear WT1 staining [26,27]. Comparing DSRCT and
Ewing Sarcoma/PNET, Hill et al. [28] detected WT1
nuclear immunoreactivity in all 13 DSRCT cases studied;
conversely, all 11 cases of Ewing Sarcoma/PNET were neg-
ative. Additionally, Wilm's tumor was demonstrated to
present a high percentage of cases with nuclear WT1 stain-
ing; for this reason, correlation with clinical findings is
necessary to do a differential diagnosis between Wilm's
tumour and DSCRT in effusions [26]. On the other hand,
it is important to emphasize that malignant mesotheli-
oma should also be considered in the differential diagno-
sis, since it can show varied histological appearances
including sarcomatoid differentiation with desmoplastic
areas, or even resembling undifferentiated sarcomas [29].
WT1 might also decorate nuclei of both epithelioid or
biphasic mesothelioma but in general, WT1 stain most
frequently epithelioid mesotheliomas [30]. The use of a
panel of markers can also help in the differential
diagnosis.
In conclusion, cytological and immunophenotypical
findings in an appropriate clinical context is sufficient to
suggest DRSTC, what sounds highly contributive for us,
considering the high aggressiveness of this tumor.
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